Tapley Holland
Phd
Biography
Meet The Speaker
Tapley Holland, Phd has been active in the stem cell and regenerative medicine field
since 2005. He developed TruDOSE™ to address the limitations of one-size-fits-all
approaches by enabling individualized dosing across a range of disease conditions.
Beginning in 2018, his research involving thousands of patients informed precision
dosing strategies and supported translational applications across multiple symptoms
and disease states. This work contributed to the completion of his PhD in Stem Cell
Medicine in February 2026 and to the publication “Platelets as Endogenous Cellular
Adaptogens: A Review of Stress Signaling and Regenerative Implications,” which
examines the role of platelets in stress response, immune modulation, and regenerative
processes. Holland’s work integrates clinical data, mechanistic insights, and
translational research to advance precision regenerative therapies for complex
neuroimmune and systemic conditions.
Rethinking Mitochondrial Dysfunction: Could the Answer to Chronic Disease Be Outside the Cell?
This presentation challenges the common view that mitochondrial dysfunction is the
primary issue to be addressed in chronic disease. Instead, it proposes an alternative
interpretation: that mitochondria may serve as reinforcement systems for adaptive
cellular states that are initiated and continuously shaped by signals from the
environment outside the cell. This perspective shifts the therapeutic focus from “How
do we fix dysfunctional mitochondria?” to “What is constantly instructing the cell to
maintain this persistent, maladaptive physiology?”
While many current strategies aim to correct internal cellular problems, this presentation
explores the idea that solutions might lie outside the cell, within the communication
environment surrounding it, which drives cellular adaptation. Using a case series of 37
pediatric patients with PANS/PANDAS, the presentation examines platelets as potential
carriers of biological information, interacting across the space outside the cell, within
signaling pathways, and regulatory networks. Finally, it considers the possibility of
precision platelet therapy as a way to recalibrate the cellular environment, influencing
the signals that sustain chronic disease and the cellular functions they maintain.
